PDS Biotechnology(PDSB) - 2024 Q2 - Quarterly Results

Exhibit 99.1 PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results PRINCETON, N.J., August 13, 2024 -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a latestage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today provided a business update and reported financial results for the second quarter of 2024. "We are exiting the second quarter with mom ...